Triple Agonist 30mg — Verification Report

From NorthStar Compounds · Lot SPRI-XJR302-60326 · Tested June 2026

← Back to NorthStar Compounds

VialTalk

Verification report

Triple Agonist 30mg

NorthStar Compounds

Score

92.7

Grade

Excellent

Lot SPRI-XJR302-60326

Tested June 2026

Report ID

bb93dd56

Test

Method

Result

Status

PurityFull credit

HPLC

99.89%

Full credit

IdentityFull credit

Mass spectrometry

Confirmed

Full credit

ContentFull credit

Gravimetric vs label claim · tested weight disclosed and verified

30 mg labeled · 33.45 mg tested

Full credit

EndotoxinNot submitted

Not tested

Not submitted

Heavy metalsNot submitted

Not tested

Not submitted

SterilityNot submitted

Not tested

Not submitted

Batch conformityNot submitted

Not tested

Not submitted

Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted.

This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →